<VariationArchive VariationID="8714" VariationName="NM_000232.5(SGCB):c.377_384dup (p.Gly129delinsGlnTer)" VariationType="Duplication" Accession="VCV000008714" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-17" DateCreated="2018-09-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23753" VariationID="8714">
      <GeneList>
        <Gene Symbol="SGCB" FullName="sarcoglycan beta" GeneID="6443" HGNC_ID="HGNC:10806" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="52020706" stop="52038299" display_start="52020706" display_stop="52038299" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="52886860" stop="52904484" display_start="52886860" display_stop="52904484" Strand="-" />
          </Location>
          <OMIM>600900</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000232.5(SGCB):c.377_384dup (p.Gly129delinsGlnTer)</Name>
      <CanonicalSPDI>NC_000004.12:52029722:TCCTACTGT:TCCTACTGTCCTACTGT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>4q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="52029722" stop="52029723" display_start="52029722" display_stop="52029723" variantLength="8" positionVCF="52029722" referenceAlleleVCF="C" alternateAlleleVCF="CTCCTACTG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="52895888" stop="52895889" display_start="52895888" display_stop="52895889" variantLength="8" positionVCF="52895888" referenceAlleleVCF="C" alternateAlleleVCF="CTCCTACTG" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000232.4" sequenceAccession="NM_000232" sequenceVersion="4" change="c.377_384dup">
            <Expression>NM_000232.4:c.377_384dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000232.5" sequenceAccession="NM_000232" sequenceVersion="5" change="c.377_384dup" MANESelect="true">
            <Expression>NM_000232.5:c.377_384dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000223.1" sequenceAccession="NP_000223" sequenceVersion="1" change="p.Gly129delinsGlnTer">
            <Expression>NP_000223.1:p.Gly129delinsGlnTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.52895890_52895897dup" Assembly="GRCh37">
            <Expression>NC_000004.11:g.52895890_52895897dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.52029724_52029731dup" Assembly="GRCh38">
            <Expression>NC_000004.12:g.52029724_52029731dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008891.1" sequenceAccession="NG_008891" sequenceVersion="1" change="g.13590_13597dup">
            <Expression>NG_008891.1:g.13590_13597dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_204" sequenceAccession="LRG_204">
            <Expression>LRG_204:g.13590_13597dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600900.0003" DB="OMIM" />
        <XRef Type="rs" ID="751427729" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000232.5(SGCB):c.377_384dup (p.Gly129delinsGlnTer) AND Autosomal recessive limb-girdle muscular dystrophy type 2E" Accession="RCV000009252" Version="13">
        <ClassifiedConditionList TraitSetID="2394">
          <ClassifiedCondition DB="MedGen" ID="C1858593">Autosomal recessive limb-girdle muscular dystrophy type 2E</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-08-11" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-11" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-09-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10662809</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10874299</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15938573</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18285821</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7581449</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2394" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5571" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy limb-girdle with beta-sarcoglycan deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-sarcoglycan limb-girdle muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2E</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2E/4240" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4</ElementValue>
                <XRef Type="MIM" ID="604286" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2E</ElementValue>
                <XRef ID="MONDO:0011423" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR4</ElementValue>
                <XRef Type="MIM" ID="604286" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism">Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.</Attribute>
                <XRef ID="GTR000509009" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3851" />
                <XRef ID="3851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="119" DB="Orphanet" />
              <XRef ID="C1858593" DB="MedGen" />
              <XRef ID="MONDO:0011423" DB="MONDO" />
              <XRef Type="MIM" ID="604286" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29470" SubmissionDate="2018-09-25" DateLastUpdated="2018-09-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600900.0003_MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4" title="SGCB, 8-BP DUP, NT383_MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4" />
        <ClinVarAccession Accession="SCV000029470" DateUpdated="2018-09-28" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 8-bp duplication in the SGCB gene that was found in compound heterozygous state in a patient with an autosomal recessive muscular dystrophy (LGMDR4; 604286) by Bonnemann et al. (1995), see 600900.0002.</Attribute>
              <Citation>
                <ID Source="PubMed">7581449</ID>
              </Citation>
              <XRef DB="OMIM" ID="604286" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 6 unrelated families with autosomal recessive muscular dystrophy from northern Italy with mutations in the beta- or gamma-sarcoglycan gene, Fanin et al. (2000) found the 8-bp duplication in the SGCB gene and a 1-bp insertion in the SGCG gene (608896.0006). Neither mutation had been found in other populations. Many patients were homozygotes, although they derived from nonconsanguineous marriages, and in each case linkage disequilibrium with neighboring polymorphisms was demonstrated. Fanin et al. (2000) presented this as an example of founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">10874299</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Barresi et al. (2000) identified the 8-bp duplication (which they referred to as 383^384ins376-383) in 2 cousins with LGMD2E. A girl, who was proven homozygous for the mutation, had severe myopathy from early infancy and was confined to a wheelchair since age 15. She had no cardiomyopathy. Muscle biopsy showed severe dystrophic features. In her male cousin, only a heterozygous 8-bp dup was identified; a second mutation in the SGCB gene was not detected, but presumed to be in a noncoding region. He developed proximal muscle weakness at age 15 years, and later developed fatal dilated cardiomyopathy. His heart muscle showed a major reduction of beta-sarcoglycan. Barresi et al. (2000) also reported an unrelated male who was compound heterozygous for the 8-bp duplication and a 4-bp deletion at the donor splice site in intron 2 (243+3delGAGT; 600900.0009), resulting in aberrant splicing and a 6-bp insertion (243insGTATTT) between exons 2 and 3. He showed onset of muscle weakness at age 4, and later developed fatal cardiomyopathy with death at age 18. The duplication mutation was predicted to produce a truncated protein lacking most of the extracellular region.</Attribute>
              <Citation>
                <ID Source="PubMed">10662809</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <Name>SGCB, 8-BP DUP, NT383</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DUP, NT383</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600900.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7857774" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000232.5:c.377_384dup|OMIM:604286" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004201010" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.5:c.377_384dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604286" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7133531" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="c365600c595e1fe796a00d3508dc585aa2612b72561751ed74d612c8d7e3db40|OMIM:604286" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003825612" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.4:c.377_384dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604286" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5717426" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="1106802|MedGen:C1858593" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003023172" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15938573</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18285821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7581449</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly129Glnfs*2) in the SGCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). This variant is present in population databases (rs751427729, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with SGCB-related conditions (PMID: 7581449). ClinVar contains an entry for this variant (Variation ID: 8714). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.52895888_52895889insTCCTACTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858593" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7133531" TraitType="Disease" MappingType="XRef" MappingValue="604286" MappingRef="OMIM">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7857774" TraitType="Disease" MappingType="XRef" MappingValue="604286" MappingRef="OMIM">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5717426" TraitType="Disease" MappingType="XRef" MappingValue="C1858593" MappingRef="MedGen">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="29470" TraitType="Disease" MappingType="Name" MappingValue="MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4" MappingRef="Preferred">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

